Synthesis and biological evaluation of amphotericin B derivatives

Natural Product Reports

Volumn 27, Issue 9, 2010, Pages 1329-1349

  Volmer, Astrid A ^a   Szpilman, Alex M ^a   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DRUG DERIVATIVE;

CHEMICAL STRUCTURE; CHEMISTRY; REVIEW; STREPTOMYCES; SYNTHESIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; STREPTOMYCES;

EID: 77955801125     PISSN: 02650568     EISSN: 14604752     Source Type: Journal    
DOI: 10.1039/b820743g     Document Type: Review

References (112)

1. H. A. Gallis R. H. Drew W. W. W. Pickard Amphotericin B 30 Years of Clinical Experience Rev. Infect. Dis. 1990 12 308 329
2. M. A. Pfaller Epidemiology and control of fungal infections Clin. Infect. Dis. 1994 19 S8 13
3. H. Wisplinghoff et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin. Infect. Dis. 2004 39 309 317
4. J. Barwicz P. Tancrede The effect of aggregation state of amphotericin-B on its interactions with cholesterol- or ergosterol-containing phosphatidylcholine monolayers Chem. Phys. Lipids 1997 85 145 155
5. D. Sanglard F. Ischer T. Parkinson D. Falconer J. Bille Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents Antimicrob. Agents Chemother. 2003 47 2404 2412
6. M. A. Ghannoum L. B. Rice Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance Clin. Microbiol. Rev. 1999 12 501 517
7. C. A. Sable K. M. Strohmaier J. A. Chodakewitz Advances in antifungal therapy Annu. Rev. Med. 2008 59 361 379
8. E. J. Helmerhorst et al. Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation J. Biol. Chem. 2001 276 5643 5649
9. A. R. Waldorf A. Polak Mechanisms of action of 5-fluorocytosine Antimicrob. Agents Chemother. 1983 23 79 85
10. R. Prasad K. Kapoor Multidrug resistance in yeast Candida Int. Rev. Cytol. 2004 242 215 248
11. J. Kotler-Brajtburg H. D. Price G. Medoff D. Schlessinger G. S. Kobayashi Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells Antimicrob. Agents Chemother. 1974 5 377 382
12. M. Herve J. C. Debouzy E. Borowski B. Cybulska C. M. Garybobo The role of the carboxyl and amino-groups of polyene macrolides in their interactions with sterols and their selective toxicity - a P-31-NMR study Biochim. Biophys. Acta, Biomembr. 1989 980 261 272
13. E. Canton J. Peman M. Gobernado A. Viudes A. Espinel-Ingroff Patterns of amphotericin B killing kinetics against seven Candida species Antimicrob. Agents Chemother. 2004 48 2477 2482
14. J. M. Hamilton-Miller Chemistry and biology of the polyene macrolide antibiotics Bacteriol. Rev. 1973 37 166 196
15. T. H. Sternberg E. T. Wright M. Oura A new antifungal antibiotic, amphotericin B Antibiot. Annu. 1955 3 566 573
16. W. Gold H. A. Stout J. F. Pagano R. Donovick Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies Antibiot. Annu. 1955 3 579 586
17. J. Vandeputte J. L. Wachtel E. T. Stiller Amphotericins A and B, antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins Antibiot. Annu. 1955 3 587 591
18. D. M. Cereghetti E. M. Carreira Amphotericin B: 50 years of chemistry and biochemistry Synthesis 2006 914 942
19. E. Borowski W. Mechlinski L. Falkowski T. Ziminski J. D. Dutcher Chemical studies on amphotericin B. II. 2-Methylheptadecanedioic acid from perhydrogenated amphotericin B Tetrahedron Lett. 1965 6 473 478
20. A. C. Cope U. Axen E. P. Burrows J. Weinlich Amphotericin B. I. Carbon skeleton ring size and partial structure J. Am. Chem. Soc. 1966 88 4228
21. W. Mechlins Cp. Schaffne P. Ganis G. Avitabil Structure and absolute configuration of polyene macrolide antibiotic amphotericin-B Tetrahedron Lett. 1970 11 3873
22. P. Ganis G. Avitabile W. Mechlinski C. P. Schaffner Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative J. Am. Chem. Soc. 1971 93 4560 4564
23. A. C. Moffat, J. V. Jackson, M. S. Moss and B. E. Widdop. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-Mortem Material (2nd edn), The Pharmaceutical Press: London, UK, 1986, p. 1223
24. S. C. Kinsky S. A. Luse L. Vandeene Interaction of polyene antibiotics with natural and artificial membrane systems Federation Proceedings 1966 25 1503
25. E. Borowski B. Cybulska Nature 1967 213 1034
26. G. Deray Amphotericin B nephrotoxicity J. Antimicrob. Chemother. 2002 49 suppl 1 37 41 (Pubitemid 34162655)
27. J. Mazerski J. Grzybowska E. Borowski Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media Eur. Biophys. J. 1990 18 159 164
28. Z. Shervani H. Etori K. Taga T. Yoshida H. Okabayashi Aggregation of polyene antibiotics as studied by electronic absorption and circular dichroism spectroscopies Colloids Surf., B 1996 7 31 38
29. A. R. Balakrishnan K. R. K. Easwaran CD and NMR-studies on the aggregation of amphotericin-B in solution Biochim. Biophys. Acta, Biomembr. 1993 1148 269 277
30. P. Legrand E. A. Romero B. E. Cohen J. Bolard Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes Antimicrob. Agents Chemother. 1992 36 2518 2522
31. B. de Kruijff R. A. Demel Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes Biochim. Biophys. Acta, Biomembr. 1974 339 57 70
32. B. de Kruijff W. J. Gerritsen A. Oerlemans R. A. Demel L. L. van Deenen Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. I. Specificity of the membrane permeability changes induced by the polyene antibiotics Biochim. Biophys. Acta 1974 339 30 43
33. + and calcein release from liposomes and the determination of pore size formed in a membrane Anal. Sci. 2007 23 517 522
34. J. Brajtburg G. Medoff G. S. Kobayashi S. Elberg C. Finegold Permeabilizing and hemolytic action of large and small polyene antibiotics on human-erythrocytes Antimicrob. Agents Chemother. 1980 18 586 592
35. T. E. Andreoli Structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes Ann. N. Y. Acad. Sci. 1974 235 448 468
36. M. Moreno-Bello M. Bonilla-Marin C. Gonzalez-Beltran Distribution of pore sizes in black lipid membranes treated with nystatin Biochim. Biophys. Acta, Biomembr. 1988 944 97 100
37. M. Bonilla-Marin M. Moreno-Bello I. Ortega-Blake A microscopic electrostatic model for the amphotericin B channel Biochim. Biophys. Acta, Biomembr. 1991 1061 65 77
38. A. Bianco K. Kostarelos C. D. Partidos M. Prato Biomedical applications of functionalised carbon nanotubes Chem. Commun. 2005 571 577 (Pubitemid 40299037)
39. J. Daillant et al. Structure and fluctuations of a single floating lipid bilayer Proc. Natl. Acad. Sci. U. S. A. 2005 102 11639 11644
40. M. Baginski H. Resat J. A. McCammon Molecular properties of amphotericin B membrane channel: a molecular dynamics simulation Mol. Pharmacol. 1997 52 560 570
41. J. A. Urbina B. E. Cohen E. Perozo L. Cornivelli Spin-labeled amphotericin B: synthesis, characterization, biological and spectroscopic properties Biochim. Biophys. Acta, Biomembr. 1987 897 467 473
42. Y. W. Hsueh et al. Ergosterol in POPC membranes: physical properties and comparison with structurally similar sterols Biophys. J. 2007 92 1606 1615
43. V. Paquet A. A. Volmer E. M. Carreira Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B Chem.-Eur. J. 2008 14 2465 2481
44. M. P. Borisova R. A. Brutyan L. N. Ermishkin Mechanism of anion-cation selectivity of amphotericin B channels J. Membr. Biol. 1986 90 13 20
45. D. G. Levitt Electrostatic calculations for an ion channel. 1. Energy and potential profiles and interactions between ions Biophys. J. 1978 22 209 219
46. V. Paquet A. Zumbuehl E. M. Carreira Biologically active amphotericin B-calix[4]arene conjugates Bioconjugate Chem. 2006 17 1460 1463
47. M. Herve B. Cybulska C. M. Garybobo Cation Permeability induced by valinomycin, gramicidin-D and amphotericin-B in large lipidic unilamellar vesicles studied by P-31-NMR Eur. Biophys. J. Biophys. Lett. 1985 12 121 128
48. P. van Hoogevest B. de Kruijff Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes Biochim. Biophys. Acta, Biomembr. 1978 511 397 407
49. Y. M. T. Welscher et al. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane J. Biol. Chem. 2008 283 6393 6401
50. + Biochim. Biophys. Acta, Biomembr. 1972 255 321 330
51. J. Bolard P. Legrand F. Heitz B. Cybulska One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium Biochemistry 1991 30 5707 5715
52. A. Cass M. Dalmark Equilibrium dialysis of ions in nystatin-treated red-cells Nature 1973 244 47 49
53. A. Zumbuehl et al. An amphotericin B-fluorescein conjugate as a powerful probe for biochemical studies of the membrane Angew. Chem., Int. Ed. 2004 43 5181 5185
54. Y. Kasai et al. Self-assembled amphotericin B is probably surrounded by ergosterol: Bimolecular interactions as evidenced by solid-state NMR and CD spectra Chem.-Eur. J. 2008 14 1178 1185
55. M. Caffrey G. W. Feigenson Fluorescence quenching in model membranes. 3. Relationship between calcium adenosine-triphosphatase enzyme-activity and the affinity of the protein for phosphatidylcholines with different acyl chain characteristics Biochemistry 1981 20 1949 1961
56. M. T. Lamy-Freund V. F. N. Ferreira S. Schreier Mechanism of inactivation of the polyene antibiotic amphotericin-B - evidence for radical formation in the process of autooxidation J. Antibiot. 1985 38 753 757
57. W. H. Beggs Kinetics of amphotericin-B decay in a liquid-medium and characterization of the decay process Curr. Microbiol. 1978 1 301 304
58. M. L. Sokol-Anderson J. Brajtburg G. Medoff Amphotericin B-induced oxidative damage and killing of Candida albicans J. Infect. Dis. 1986 154 76 83
59. J. Brajtburg S. Elberg G. Medoff G. S. Kobayashi Increase in colony-forming units of Candida albicans after treatment with polyene antibiotics Antimicrob. Agents Chemother. 1981 19 199 200
60. 1H-NMR and biochemical methods Eur. J. Biochem. 1991 197 271 279
61. M. Siderius W. H. Mager Conditional response to stress in yeast Monatsh. Chem. 2003 134 1433 1444
62. P. Caffrey S. Lynch E. Flood S. Finnan M Oliynyk Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes Chem. Biol. 2001 8 713 723
63. J. F. Aparicio P. Caffrey J. A. Gil S. B Zotchev Polyene antibiotic biosynthesis gene clusters Appl. Microbiol. Biotechnol. 2003 61 179 188
64. C. M. McNamara et al. Biosynthesis of amphotericin B J. Chem. Soc., Perkin Trans. 1 1998 83 87
65. D. R. Worthen M. Jay P. M. Bummer Methods for the recovery and purification of polyene antifungals Drug Dev. Ind. Pharm. 2001 27 277 286
66. J. Nikodinovic K. D. Barrow J. A. Chuck High frequency transformation of the amphotericin-producing bacterium Streptomyces nodosus J. Microbiol. Methods 2003 55 273 277
67. B. Byrne M. Carmody E. Gibson B. Rawlings P. Caffrey Biosynthesis of deoxyamphotericins and deoxyamphoteronolides by engineered strains of Streptomyces nodosus Chem. Biol. 2003 10 1215 1224
68. P. Caffrey J. F. Aparicio F. Malpartida S. B. Zotchev Biosynthetic engineering of polyene macrolides towards generation of improved antifungal and antiparasitic agents Curr. Top. Med. Chem. 2008 8 639 653
69. D. S. Palacios T. M. Anderson M. D. Burke A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity J. Am. Chem. Soc. 2007 129 13804 13805
70. M. Cheron et al. Quantitative structure-activity relationships in amphotericin B derivatives Biochem. Pharmacol. 1988 37 827 836
71. A. Czerwinski J. Grzybowska E. Borowski N-Dimethylaminoacyl derivatives of polyene macrolide antibiotics J. Antibiot. (Tokyo) 1986 39 1025 1027
72. J. Grzybowska P. Sowinski J. Gumieniak T. Zieniawa E. Borowski N-Methyl-N-d-fructopyranosylamphotericin B methyl ester, new amphotericin B derivative of low toxicity J. Antibiot. (Tokyo) 1997 50 709 711
73. K. Hac-Wydro P. Dynarowicz-Latka J. Grzybowska E. Borowski N-(1-Piperidinepropionyl)amphotericin B methyl ester (PAME) - a new derivative of the antifungal antibiotic amphotericin B: searching for the mechanism of its reduced toxicity J. Colloid Interface Sci. 2005 287 476 484
74. D. L. Oblack W. L. Hewitt W. J. Martin Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives Antimicrob. Agents Chemother. 1981 19 106 109
75. J. J. K. Wright J. A. Albarella L. R. Krepski D. Loebenberg N-Aminoacyl derivatives of polyene macrolide antibiotics and their esters J. Antibiot. 1982 35 911 914
76. V. V. Belakov Y. D. Shenin Synthesis and antifungal activity of N-benzyl derivatives of amphotericin B Pharm. Chem. J. (Transl. from Khim.-Farm. Zh.) 2007 41 362 366
77. V. Paquet E. M. Carreira Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine Org. Lett. 2006 8 1807 1809
78. 3CN Tetrahedron Lett. 1994 35 1181 1184
79. R. F. Borch Md. Bernstei H. D. Durst Cyanohydridoborate anion as a selective reducing agent J. Am. Chem. Soc. 1971 93 2897
80. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast, M27-A2, Approved Standard (2nd edn), 1995, vol. 22, no. 15
81. M. J. Driver A. R. Greenless W. S. Maclachlan D. T. Macpherson A. W. Taylor Synthesis of 16-decarboxy-16-hydroxymethyl amphotericin-B - a novel antifungal agent Tetrahedron Lett. 1992 33 4357 4360
82. M. J. Driver W. S. Maclachlan D. T. Macpherson S. A. Readshaw The chemistry of amphotericin-B - synthesis of 13,14-anhydro derivatives J. Chem. Soc., Chem. Commun. 1990 636 638
83. M. J. Driver A. R. Greenlees D. T. Macpherson A versatile strategy for the derivatization of the carboxy group of amphotericin-B - the preparation of C-16 ketone analogs J. Chem. Soc., Perkin Trans. 1 1992 3155 3157
84. J. P. Begue D. Bonnet-Delpon Recent advances (1995-2005) in fluorinated pharmaceuticals based on natural products J. Fluorine Chem. 2006 127 992 1012
85. W. S. Maclachlan, U.S. Patent 6,284,736, 2001
86. N. Matsumori Y. Umegawa T. Oishi M. Murata Bioactive fluorinated derivative of amphotericin B Bioorg. Med. Chem. Lett. 2005 15 3565 3567
87. M. Larabi et al. Study of the toxicity of a new lipid complex formulation of amphotericin B J. Antimicrob. Chemother. 2004 53 81 88
88. A. Lemke A. F. Kiderlen O. Kayser Appl. Microbiol. Biotechnol. 2005 68 151 162
89. E. Borowski et al., Salts of N-glycosyl derivatives of polyene macrolides, especially N-methylglucamine salts as well as the method of their preparation, Instytut Przemyslu Farmaceutycznego, Politechnika Gdanska, Poland, 1980, p. 5
90. R. Falk A. J. Domb I. Polacheck A novel injectable water-soluble amphotericin B-arabinogalactan conjugate Antimicrob. Agents Chemother. 1999 43 1975 1981
91. T. Ehrenfreund-Kleinman et al. Synthesis and characterization of novel water-soluble amphotericin B-arabinogalactan conjugates Biomaterials 2002 23 1327 1335
92. M. F. Adams C. Douglas Arabinogalactan. A review of the literature TAPPI J. 1963 46 544 558
93. T. Ehrenfreund-Kleinman J. Golenser A. J. Domb Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates Biomaterials 2004 25 3049 3057
94. M. Sedlak et al. Synthesis and characterisation of a new amphotericin B-methoxypoly(ethylene glycol) conjugate Bioorg. Med. Chem. Lett. 2001 11 2833 2835
95. C. D. Conover H. Zhao C. B. Longley K. L. Shum R. B. Greenwald Utility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin B Bioconjugate Chem. 2003 14 661 666
96. R. B. Greenwald et al. Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds J. Med. Chem. 1999 42 3657 3667
97. M. Sedlak et al. Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro Bioorg. Med. Chem. 2007 15 4069 4076
98. N. Matsumori et al. An amphotericin B-ergosterol covalent conjugate with powerful membrane permeabilizing activity Chem. Biol. 2004 11 673 679
99. S. Matsuoka N. Matsumori M. Murata Amphotericin B-phospholipid covalent conjugates: dependence of membrane-permeabilizing activity on acyl-chain length Org. Biomol. Chem. 2003 1 3882 3884
100. A. Zumbuehl et al. A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B Org. Biomol. Chem. 2007 5 1339 1342
101. A. Zumbuehl et al. Synthesis and investigation of tryptophan-amphotericin B conjugates ChemBioChem 2009 10 1617 1620
102. N. Matsumori N. Yamaji S. Matsuoka T. Oishi M. Murata Amphotericin B covalent dimers forming sterol-dependent ion-permeable membrane channels J. Am. Chem. Soc. 2002 124 4180 4181
103. N. Matsumori R. Masuda M. Murata Amphotericin B covalent dimers bearing a tartarate linkage Chem. Biodiversity 2004 1 346 352
104. N. Yamaji N. Matsumori S. Matsuoka T. Oishi M. Murata Amphotericin B dimers with bisamide linkage bearing powerful membrane-permeabilizing activity Org. Lett. 2002 4 2087 2089
105. W. Wu et al. Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes Angew. Chem., Int. Ed. 2005 44 6358 6362
106. M. D. Alexander et al. A central strategy for converting natural products into fluorescent probes ChemBioChem 2006 7 409 416
107. R. M. Wilson S. J. Danishefsky Small molecule natural products in the discovery of therapeutic agents: the synthesis connection J. Org. Chem. 2006 71 8329 8351
108. A. M. Szpilman D. M. Cereghetti N. R. Wurtz J. M. Manthorpe E. M. Carreira Synthesis of 35-deoxy amphotericin B methyl ester: a strategy for molecular editing Angew. Chem., Int. Ed. 2008 47 4335 4338
109. J. Tholander E. M. Carreira Asymmetric synthesis of the C(33)-C(37) fragment of amphotericin B Helv. Chim. Acta 2001 84 613 622
110. J. M. Manthorpe A. M. Szpilman E. M. Carreira Scalable synthesis of a mycosamine donor. Overcoming difficult reactivity in allose systems Synthesis 2005 3380 3388
111. A. M. Szpilman J. M. Manthorpe E. M. Carreira Synthesis and biological studies of 35-deoxy amphotericin B methyl ester Angew. Chem., Int. Ed. 2008 47 4339 4342
112. A. M. Szpilman D. M. Cereghetti N. R. Wurtz J. M. Manthorpe E. M. Carreira Synthesis and Biophysical Studies on 35-Deoxy-Amphotericin B Methyl Ester Chem.-Eur. J. 2009 15 7117 7128